$CYAN
CYANOTECH CORP

2019 Q1 Form 10-K Financial Statement

#000143774920013699 Filed on June 23, 2020

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q4 2018 Q3
Revenue $6.059M $10.04M $6.954M
YoY Change -25.21% 9.77% -13.67%
Cost Of Revenue $3.830M $5.928M $4.669M
YoY Change -38.13% 20.73% 5.28%
Gross Profit $2.229M $4.116M $2.285M
YoY Change 16.82% -2.92% -36.88%
Gross Profit Margin 36.79% 40.98% 32.86%
Selling, General & Admin $3.260M $3.405M $3.078M
YoY Change 20.3% 13.96% 7.92%
% of Gross Profit 146.25% 82.73% 134.7%
Research & Development $290.0K $216.0K $211.0K
YoY Change 123.08% 52.11% 41.61%
% of Gross Profit 13.01% 5.25% 9.23%
Depreciation & Amortization $490.0K $471.0K $475.0K
YoY Change 2.08% 2.39% 3.26%
% of Gross Profit 21.98% 11.44% 20.79%
Operating Expenses $3.550M $3.621M $3.289M
YoY Change 24.56% 15.69% 9.6%
Operating Profit -$1.321M $495.0K -$1.004M
YoY Change 40.23% -55.41% -262.2%
Interest Expense -$170.0K $134.0K $150.0K
YoY Change 30.77% -203.08% -212.78%
% of Operating Profit 27.07%
Other Income/Expense, Net
YoY Change
Pretax Income -$1.490M $361.0K -$1.154M
YoY Change 40.57% -63.16% -337.45%
Income Tax -$20.00K $73.00K -$18.00K
% Of Pretax Income 20.22%
Net Earnings -$1.473M $288.0K -$1.136M
YoY Change 39.22% -73.98% -339.16%
Net Earnings / Revenue -24.31% 2.87% -16.34%
Basic Earnings Per Share $0.05 -$0.20
Diluted Earnings Per Share -$251.3K $0.05 -$0.20
COMMON SHARES
Basic Shares Outstanding 5.836M 5.806M
Diluted Shares Outstanding 5.862M 5.806M

Balance Sheet

Concept 2019 Q1 2018 Q4 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $840.0K $1.570M $660.0K
YoY Change -36.84% -10.8% -68.57%
Cash & Equivalents $840.0K $1.573M $663.0K
Short-Term Investments
Other Short-Term Assets $500.0K $640.0K $700.0K
YoY Change -15.25% 16.36% 55.56%
Inventory $11.27M $10.11M $10.44M
Prepaid Expenses
Receivables $1.982M $1.883M $1.882M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $14.59M $14.21M $13.68M
YoY Change 7.16% -4.92% 2.08%
LONG-TERM ASSETS
Property, Plant & Equipment $14.75M $15.18M $15.12M
YoY Change -6.24% -4.78% -5.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $282.0K $291.0K $298.0K
YoY Change -3.09% -8.2% 18.73%
Total Long-Term Assets $15.03M $15.47M $15.42M
YoY Change -6.56% -5.22% -5.25%
TOTAL ASSETS
Total Short-Term Assets $14.59M $14.21M $13.68M
Total Long-Term Assets $15.03M $15.47M $15.42M
Total Assets $29.63M $29.68M $29.10M
YoY Change -0.27% -5.08% -1.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.922M $4.055M $4.295M
YoY Change 39.55% 12.95% 23.67%
Accrued Expenses $992.0K $1.073M $811.0K
YoY Change 11.21% -20.22% -19.86%
Deferred Revenue $626.0K $172.0K
YoY Change 370.68%
Short-Term Debt $2.290M $2.080M $1.750M
YoY Change 358.0% 316.0% 250.0%
Long-Term Debt Due $2.663M $660.0K $660.0K
YoY Change 130.56% 0.0% 4.76%
Total Short-Term Liabilities $9.488M $8.045M $7.602M
YoY Change 66.25% 31.24% 33.77%
LONG-TERM LIABILITIES
Long-Term Debt $5.172M $5.330M $5.480M
YoY Change -10.67% -10.42% -8.05%
Other Long-Term Liabilities $57.00K $60.00K $90.00K
YoY Change -43.0% -45.45% -18.18%
Total Long-Term Liabilities $5.229M $5.390M $5.570M
YoY Change -11.22% -11.06% -8.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.488M $8.045M $7.602M
Total Long-Term Liabilities $5.229M $5.390M $5.570M
Total Liabilities $14.72M $13.43M $13.18M
YoY Change 26.87% 10.21% 12.13%
SHAREHOLDERS EQUITY
Retained Earnings -$17.66M -$16.18M -$16.47M
YoY Change 25.58% 24.47% 16.75%
Common Stock $117.0K $117.0K $117.0K
YoY Change 1.74% 1.74% 1.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.91M $16.25M $15.93M
YoY Change
Total Liabilities & Shareholders Equity $29.63M $29.68M $29.10M
YoY Change -0.27% -5.08% -1.94%

Cashflow Statement

Concept 2019 Q1 2018 Q4 2018 Q3
OPERATING ACTIVITIES
Net Income -$1.473M $288.0K -$1.136M
YoY Change 39.22% -73.98% -339.16%
Depreciation, Depletion And Amortization $490.0K $471.0K $475.0K
YoY Change 2.08% 2.39% 3.26%
Cash From Operating Activities -$810.0K $1.270M -$440.0K
YoY Change -4150.0% 1487.5% -137.29%
INVESTING ACTIVITIES
Capital Expenditures -$50.00K -$140.0K -$170.0K
YoY Change -85.29% -64.1% -22.73%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$50.00K -$140.0K -$170.0K
YoY Change -85.29% -68.89% -22.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 120.0K -220.0K 340.0K
YoY Change -200.0% -650.0% -312.5%
NET CHANGE
Cash From Operating Activities -810.0K 1.270M -440.0K
Cash From Investing Activities -50.00K -140.0K -170.0K
Cash From Financing Activities 120.0K -220.0K 340.0K
Net Change In Cash -740.0K 910.0K -270.0K
YoY Change 68.18% -375.76% -133.75%
FREE CASH FLOW
Cash From Operating Activities -$810.0K $1.270M -$440.0K
Capital Expenditures -$50.00K -$140.0K -$170.0K
Free Cash Flow -$760.0K $1.410M -$270.0K
YoY Change -311.11% 200.0% -119.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 cyan Deferred Tax Assets Interest Limitation
DeferredTaxAssetsInterestLimitation
174000
CY2018Q1 cyan Deferred Tax Assets Interest Limitation
DeferredTaxAssetsInterestLimitation
CY2020Q1 cyan Accrued Rent And Utilities Current
AccruedRentAndUtilitiesCurrent
76000
CY2019Q1 cyan Accrued Rent And Utilities Current
AccruedRentAndUtilitiesCurrent
235000
CY2020 cyan Adjustments To Additional Paid In Capital Settlement Agreement With A Former Executive
AdjustmentsToAdditionalPaidInCapitalSettlementAgreementWithAFormerExecutive
320000
CY2020Q1 cyan Deferred Tax Assets Interest Limitation
DeferredTaxAssetsInterestLimitation
3000
CY2020Q1 cyan Deferred Tax Assets Operating Lease Right Of Use Assets
DeferredTaxAssetsOperatingLeaseRightOfUseAssets
1108000
CY2019Q1 cyan Deferred Tax Assets Operating Lease Right Of Use Assets
DeferredTaxAssetsOperatingLeaseRightOfUseAssets
CY2018Q1 cyan Deferred Tax Assets Operating Lease Right Of Use Assets
DeferredTaxAssetsOperatingLeaseRightOfUseAssets
CY2020 cyan Effective Income Tax Rate Reconciliation Change In Applicable Tax Rate Amount
EffectiveIncomeTaxRateReconciliationChangeInApplicableTaxRateAmount
CY2019 cyan Effective Income Tax Rate Reconciliation Change In Applicable Tax Rate Amount
EffectiveIncomeTaxRateReconciliationChangeInApplicableTaxRateAmount
CY2018 cyan Effective Income Tax Rate Reconciliation Change In Applicable Tax Rate Amount
EffectiveIncomeTaxRateReconciliationChangeInApplicableTaxRateAmount
1244000
CY2020 cyan Finance Lease Cost
FinanceLeaseCost
25000
CY2020 cyan Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-289000
CY2019 cyan Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
CY2018 cyan Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
CY2020 cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
0
CY2019 cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
250000
CY2018 cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
538000
CY2020 cyan Issuance Of Short Term Obligations
IssuanceOfShortTermObligations
CY2019 cyan Issuance Of Short Term Obligations
IssuanceOfShortTermObligations
-395000
CY2018 cyan Issuance Of Short Term Obligations
IssuanceOfShortTermObligations
CY2020Q1 cyan Long Term Debt And Capital Lease Obligations Current And Noncurrent
LongTermDebtAndCapitalLeaseObligationsCurrentAndNoncurrent
5249000
CY2020Q1 cyan Longterm Debt Current Maturities Excluding Line Of Credit Current
LongtermDebtCurrentMaturitiesExcludingLineOfCreditCurrent
689000
CY2019Q1 cyan Longterm Debt Current Maturities Excluding Line Of Credit Current
LongtermDebtCurrentMaturitiesExcludingLineOfCreditCurrent
663000
CY2020Q1 cyan Longterm Debt Gross Excluding Current Maturities
LongtermDebtGrossExcludingCurrentMaturities
6178000
CY2019Q1 cyan Longterm Debt Gross Excluding Current Maturities
LongtermDebtGrossExcludingCurrentMaturities
5372000
CY2020 cyan Non Inventoriable Fixed Costs
NonInventoriableFixedCosts
343000
CY2019 cyan Non Inventoriable Fixed Costs
NonInventoriableFixedCosts
176000
CY2018 cyan Non Inventoriable Fixed Costs
NonInventoriableFixedCosts
271000
CY2020Q1 cyan Number Of Shareholder Approved Sharebased Compensation Plans
NumberOfShareholderApprovedSharebasedCompensationPlans
2
CY2020 cyan Operating Lease Rightofuse Asset Amortization
OperatingLeaseRightofuseAssetAmortization
294000
CY2019 cyan Operating Lease Rightofuse Asset Amortization
OperatingLeaseRightofuseAssetAmortization
CY2018 cyan Operating Lease Rightofuse Asset Amortization
OperatingLeaseRightofuseAssetAmortization
CY2020 cyan Operating Leases Expense Contingent Rentals
OperatingLeasesExpenseContingentRentals
49000
CY2019 cyan Operating Leases Expense Contingent Rentals
OperatingLeasesExpenseContingentRentals
54000
CY2018 cyan Operating Leases Expense Contingent Rentals
OperatingLeasesExpenseContingentRentals
49000
CY2020 cyan Payments For Property Taxes
PaymentsForPropertyTaxes
28000
CY2019 cyan Payments For Property Taxes
PaymentsForPropertyTaxes
29000
CY2018 cyan Payments For Property Taxes
PaymentsForPropertyTaxes
11000
CY2020 cyan Proceeds From Issuance Of Common Stock And Stock Options Exercised
ProceedsFromIssuanceOfCommonStockAndStockOptionsExercised
4000
CY2019 cyan Proceeds From Issuance Of Common Stock And Stock Options Exercised
ProceedsFromIssuanceOfCommonStockAndStockOptionsExercised
108000
CY2018 cyan Proceeds From Issuance Of Common Stock And Stock Options Exercised
ProceedsFromIssuanceOfCommonStockAndStockOptionsExercised
75000
CY2020 cyan Repayments Of Short Term Contractual Obligation
RepaymentsOfShortTermContractualObligation
247000
CY2019 cyan Repayments Of Short Term Contractual Obligation
RepaymentsOfShortTermContractualObligation
110000
CY2018 cyan Repayments Of Short Term Contractual Obligation
RepaymentsOfShortTermContractualObligation
CY2020 cyan Shareased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0
CY2019 cyan Shareased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0
CY2018 cyan Shareased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0
CY2020 cyan Sharebased Compensation Arrangement By Share Based Payment Award Weighted Average Grant Date Fair Value Optionsgranted
SharebasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageGrantDateFairValueOptionsgranted
5000
CY2019 cyan Sharebased Compensation Arrangement By Share Based Payment Award Weighted Average Grant Date Fair Value Optionsgranted
SharebasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageGrantDateFairValueOptionsgranted
76000
CY2018 cyan Sharebased Compensation Arrangement By Share Based Payment Award Weighted Average Grant Date Fair Value Optionsgranted
SharebasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageGrantDateFairValueOptionsgranted
67000
CY2020 cyan Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Vesting Period
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsVestingPeriod
P0Y
CY2019 cyan Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Vesting Period
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsVestingPeriod
P4Y
CY2018 cyan Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Vesting Period
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsVestingPeriod
P3Y
CY2020Q1 cyan Sharesauthorized
Sharesauthorized
60000000
CY2018 cyan Stock Issued During Period Value Director Stockgrants
StockIssuedDuringPeriodValueDirectorStockgrants
276000
CY2019 cyan Stock Issued During Period Value Director Stockgrants
StockIssuedDuringPeriodValueDirectorStockgrants
170000
CY2020 cyan Stock Issued During Period Value Director Stockgrants
StockIssuedDuringPeriodValueDirectorStockgrants
158000
CY2020Q1 cyan Working Capital Deficit
WorkingCapitalDeficit
8369000
CY2019Q1 cyan Working Capital Deficit
WorkingCapitalDeficit
5104000
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0000768408
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6028312
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q3 dei Entity Public Float
EntityPublicFloat
7852346
CY2020 dei Entity Registrant Name
EntityRegistrantName
Cyanotech Corp
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Security12b Title
Security12bTitle
Common Stock, $0.02 par value per share
CY2020 dei Trading Symbol
TradingSymbol
cyan
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13000
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
27000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
80000
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
71000
CY2018 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
72000
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2137000
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4922000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2154000
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1982000
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
849000
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
992000
CY2020Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
295000
CY2019Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
145000
CY2020Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
301000
CY2019Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
338000
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21179000
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19254000
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32994000
CY2019Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32447000
CY2019 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
CY2020 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
124000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
152000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
99000
CY2020 us-gaap Advertising Expense
AdvertisingExpense
1992000
CY2019 us-gaap Advertising Expense
AdvertisingExpense
2413000
CY2018 us-gaap Advertising Expense
AdvertisingExpense
1548000
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
0
CY2019Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
0
CY2020Q1 us-gaap Assets
Assets
31787000
CY2019Q1 us-gaap Assets
Assets
29626000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
14728000
CY2019Q1 us-gaap Assets Current
AssetsCurrent
14592000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2417000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
840000
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1329000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
840000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1394000
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1407000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2417000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1577000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-554000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13000
CY2020Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1917000
CY2019Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
340000
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
117000
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin: 0pt 0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Concentration Risk</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin: 0pt 0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin: 0pt 0pt;text-align:justify;text-indent:36pt;">The Company maintains its cash accounts in banks located in Hawaii, which are insured by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) up to <div style="display: inline; font-style: italic; font: inherit;">$250,000</div> per bank.&nbsp; The Company had cash balances at <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019</div> that exceeded the balance insured by the FDIC by <div style="display: inline; font-style: italic; font: inherit;">$1,917,000</div> and <div style="display: inline; font-style: italic; font: inherit;">$340,000,</div> respectively.&nbsp; A significant portion of revenues and accounts receivables are derived from a few major customers. For the year ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020, </div><div style="display: inline; font-style: italic; font: inherit;">two</div> customers accounted for <div style="display: inline; font-style: italic; font: inherit;">33%</div> and <div style="display: inline; font-style: italic; font: inherit;">18%</div> of the Company&#x2019;s total net sales and for the year ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2019, </div><div style="display: inline; font-style: italic; font: inherit;">two</div> customers accounted for <div style="display: inline; font-style: italic; font: inherit;">33%</div> and <div style="display: inline; font-style: italic; font: inherit;">24%</div> of the Company&#x2019;s total net sales. For the year ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2017, </div><div style="display: inline; font-style: italic; font: inherit;">two</div> customers accounted for <div style="display: inline; font-style: italic; font: inherit;">32%</div> and <div style="display: inline; font-style: italic; font: inherit;">15%</div> of our total net sales. <div style="display: inline; font-style: italic; font: inherit;">Two</div> and <div style="display: inline; font-style: italic; font: inherit;">three</div> customers accounted for <div style="display: inline; font-style: italic; font: inherit;">80%</div> and <div style="display: inline; font-style: italic; font: inherit;">60%</div>, respectively,&nbsp;of the Company&#x2019;s accounts receivable balance as of <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019,</div> respectively.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin: 0pt 0pt;text-align:justify;text-indent:36pt;"></div></div></div></div></div></div></div>
CY2020Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
275000
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2019Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
256000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6011885
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5879710
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6011885
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5879710
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
120000
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
327000
CY2019Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
626000
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
550000
CY2019 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
133000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19199000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19736000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20744000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-3000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-4000
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-112000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
9000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
17000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-110000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
12000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
21000
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2020Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
169000
CY2019Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
200000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
CY2020Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2482000
CY2019Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1308000
CY2018Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1251000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2020Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5495000
CY2019Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4480000
CY2018Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3409000
CY2020Q1 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
492000
CY2019Q1 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
509000
CY2018Q1 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
295000
CY2020Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2019Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2018Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2020Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2482000
CY2019Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1308000
CY2018Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1251000
CY2020Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3703000
CY2019Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3611000
CY2018Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2903000
CY2020Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
25000
CY2019Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
27000
CY2018Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
22000
CY2020Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
28000
CY2019Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
28000
CY2018Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
36000
CY2020Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
136000
CY2019Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
131000
CY2018Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
153000
CY2020Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3013000
CY2019Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3172000
CY2018Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2158000
CY2020Q1 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
1106000
CY2019Q1 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
CY2018Q1 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
CY2020Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1376000
CY2019Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1308000
CY2018Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1251000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1934000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1908000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1877000
CY2020 us-gaap Dilutive Securities
DilutiveSecurities
CY2018 us-gaap Dilutive Securities
DilutiveSecurities
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.62
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.04
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.03
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.01
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.06
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.05
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3079
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
CY2019 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
CY2018 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-106000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5281000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5718000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4956000
CY2020 us-gaap Gross Profit
GrossProfit
12700000
CY2019 us-gaap Gross Profit
GrossProfit
10466000
CY2018 us-gaap Gross Profit
GrossProfit
13371000
CY2019Q2 us-gaap Gross Profit
GrossProfit
3676000
CY2019Q3 us-gaap Gross Profit
GrossProfit
3063000
CY2019Q4 us-gaap Gross Profit
GrossProfit
2877000
CY2020Q1 us-gaap Gross Profit
GrossProfit
3084000
CY2018Q2 us-gaap Gross Profit
GrossProfit
1836000
CY2018Q3 us-gaap Gross Profit
GrossProfit
2285000
CY2018Q4 us-gaap Gross Profit
GrossProfit
4116000
CY2019Q1 us-gaap Gross Profit
GrossProfit
2229000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
396000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3579000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
915000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-110000
CY2019 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
1200000
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-159000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1015000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1565000
CY2020 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
32000
CY2019 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
30000
CY2018 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-3000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
114000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-752000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
282000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
13000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-6000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
11000
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
10000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-2000
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-3000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-264000
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
36000
CY2020 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
3000
CY2019 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
4000
CY2018 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
112000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2785000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1395000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-139000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
172000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-682000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
529000
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-143000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
100000
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-121000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-299000
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
493000
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
13000
CY2020 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-3000
CY2019 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-46000
CY2018 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-13000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1621000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2240000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1062000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-41000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-64000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
139000
CY2020 us-gaap Interest Expense
InterestExpense
657000
CY2019 us-gaap Interest Expense
InterestExpense
582000
CY2018 us-gaap Interest Expense
InterestExpense
499000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
618000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
380000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
413000
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4945000
CY2019Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6587000
CY2020Q1 us-gaap Inventory Net
InventoryNet
9653000
CY2019Q1 us-gaap Inventory Net
InventoryNet
11274000
CY2020Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
397000
CY2019Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
495000
CY2020Q1 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
139000
CY2019Q1 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
160000
CY2020Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4172000
CY2019Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4032000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2207000
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6009000
CY2019Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5172000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
558000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
824000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-498000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-224000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6158000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3693000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
593000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
371000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
371000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
537000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
593000
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2320000
CY2020Q1 us-gaap Liabilities
Liabilities
15941000
CY2019Q1 us-gaap Liabilities
Liabilities
14717000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31787000
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29626000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6359000
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
9488000
CY2020Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2000000
CY2020Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2000000
CY2019Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2000000
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
6867000
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2689000
CY2019Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2663000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
2870000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
689000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
302000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
285000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
513000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-531000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1005000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1243000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-847000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1490000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
387000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-3596000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
1025000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-133000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
228000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
171000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
121000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-1275000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-1136000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
288000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-1473000
CY2020 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
387000
CY2018 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
1025000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-657000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-582000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-499000
CY2020 us-gaap Operating Expenses
OperatingExpenses
11647000
CY2019 us-gaap Operating Expenses
OperatingExpenses
13463000
CY2018 us-gaap Operating Expenses
OperatingExpenses
11957000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
1053000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-2997000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
1414000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
592000
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
623000
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
588000
CY2018 us-gaap Operating Lease Expense
OperatingLeaseExpense
578000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3838000
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
319000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3519000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3834000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.075
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P13Y328D
CY2020Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
14961000
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
177000
CY2019Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
274000
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
183000
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
282000
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
54000
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
57000
CY2020 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
224000
CY2019 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
431000
CY2018 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
1005000
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
31000
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
32000
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
CY2020 us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
CY2019 us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
100000
CY2018 us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
504000
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
496000
CY2020 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
CY2019 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
CY2018 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
166000
CY2020 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1500000
CY2019 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
CY2018 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
CY2020 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
CY2019 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
1500000
CY2018 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
538000
CY2015Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
500000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
608000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
923000
CY2018 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-111000
CY2018Q1 us-gaap Purchase Obligation
PurchaseObligation
449000
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
33946000
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
33750000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13042000
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14752000
CY2020Q1 us-gaap Purchase Obligation
PurchaseObligation
825000
CY2019Q1 us-gaap Purchase Obligation
PurchaseObligation
951000
CY2020 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
57000
CY2019 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
66000
CY2018 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
90000
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
611000
CY2019 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
576000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
563000
CY2019Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
CY2018Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
65000
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17268000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17655000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31899000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30202000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34115000
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8071000
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7690000
CY2019Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7504000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8634000
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
31899000
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7145000
CY2018Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6954000
CY2018Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
10044000
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6059000
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
30202000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5758000
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6822000
CY2018 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6438000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
577000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
322000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
400000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
435790
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
169000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
72000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
57000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
1.10
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
3
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
3.83
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5061
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4994
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5191
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0147
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.024
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.025
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
1650000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1367815
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
280800
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.22
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
77000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
67000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
750
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
50000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
120000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3700
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
104388
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
120000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
50000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.10
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
145946
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
675300
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
675300
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
503000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
589400
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
539800
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
318300
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.10
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.06
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.06
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.08
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.59
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.17
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.08
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
1.60
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
4.82
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
3.53
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-31000
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
37500
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.70
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.52
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y255D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y328D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y328D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
97500
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.74
CY2020Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
2.29
CY2020Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
4.08
CY2020 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.50
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.58
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.53
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.11
CY2020Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
280800
CY2020Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
318300
CY2020Q1 us-gaap Share Price
SharePrice
2.06
CY2019Q1 us-gaap Share Price
SharePrice
3.24
CY2018Q1 us-gaap Share Price
SharePrice
5.10
CY2017Q1 us-gaap Share Price
SharePrice
3.85
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y328D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y109D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y109D
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
130000
CY2020Q1 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
38000
CY2019Q1 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
285000
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
29150
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
49600
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2112
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-32000
CY2020Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
75000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
108000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
15846000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
14909000
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
16607000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
18107000
CY2020Q1 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
28000
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin: 0pt 0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin: 0pt 0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin: 0pt 0pt;text-align:justify;text-indent:36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of any contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the periods reported.&nbsp; Management reviews these estimates and assumptions periodically and reflects the effect of revisions in the period that they are determined to be necessary.&nbsp; Actual results could differ from those estimates and assumptions.</div></div></div></div></div></div></div>
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5000
CY2018 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
72000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5961000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5819000
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5781000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5819000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5956000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5819000
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5709000

Files In Submission

Name View Source Status
0001437749-20-013699-index-headers.html Edgar Link pending
0001437749-20-013699-index.html Edgar Link pending
0001437749-20-013699.txt Edgar Link pending
0001437749-20-013699-xbrl.zip Edgar Link pending
cyan-20200331.xml Edgar Link completed
cyan-20200331.xsd Edgar Link pending
cyan-20200331_cal.xml Edgar Link unprocessable
cyan-20200331_def.xml Edgar Link unprocessable
cyan-20200331_lab.xml Edgar Link unprocessable
cyan-20200331_pre.xml Edgar Link unprocessable
cyan20200331_10k.htm Edgar Link pending
ex_188089.htm Edgar Link pending
ex_188090.htm Edgar Link pending
ex_188091.htm Edgar Link pending
ex_188092.htm Edgar Link pending
ex_188093.htm Edgar Link pending
ex_188093img001.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending